248 related articles for article (PubMed ID: 3956263)
1. Suppression of tumorigenicity in somatic cell hybrids. III. Cosegregation of human chromosome 11 of a normal cell and suppression of tumorigenicity in intraspecies hybrids of normal diploid x malignant cells.
Kaelbling M; Klinger HP
Cytogenet Cell Genet; 1986; 41(2):65-70. PubMed ID: 3956263
[TBL] [Abstract][Full Text] [Related]
2. Suppression of tumorigenicity in somatic cell hybrids. IV. Chromosomes of normal human cells associated with suppression of tumorigenicity in hybrids with D98AH2 carcinoma cells.
Klinger HP; Kaelbling M
Cytogenet Cell Genet; 1986; 42(4):225-35. PubMed ID: 3463446
[TBL] [Abstract][Full Text] [Related]
3. Suppression of tumorigenicity in somatic cell hybrids. II. Human chromosomes implicated as suppressors of tumorigenicity in hybrids with Chinese hamster ovary cells.
Klinger HP; Shows TB
J Natl Cancer Inst; 1983 Sep; 71(3):559-69. PubMed ID: 6577230
[TBL] [Abstract][Full Text] [Related]
4. Levels of fos, ets2, and myb proto-oncogene RNAs correlate with segregation of chromosome 11 of normal cells and with suppression of tumorigenicity in human cell hybrids.
O'Hara BM; Klinger HP; Curran T; Zhang YD; Blair DG
Mol Cell Biol; 1987 Aug; 7(8):2941-6. PubMed ID: 3670301
[TBL] [Abstract][Full Text] [Related]
5. Tumorigenicity of mouse-human diploid hybrids in nude mice.
Croce CM; Aden C; Koprowski H
Science; 1975 Dec; 190(4220):1200-2. PubMed ID: 173020
[TBL] [Abstract][Full Text] [Related]
6. Tumorigenicity of human HT1080 fibrosarcoma X normal fibroblast hybrids: chromosome dosage dependency.
Benedict WF; Weissman BE; Mark C; Stanbridge EJ
Cancer Res; 1984 Aug; 44(8):3471-9. PubMed ID: 6744274
[TBL] [Abstract][Full Text] [Related]
7. Implication of chromosome 11 in the suppression of neoplastic expression in human cell hybrids.
Srivatsan ES; Benedict WF; Stanbridge EJ
Cancer Res; 1986 Dec; 46(12 Pt 1):6174-9. PubMed ID: 2877730
[TBL] [Abstract][Full Text] [Related]
8. Suppression of tumorigenicity in hybrids of tumorigenic Chinese hamster cells and diploid mouse fibroblasts: dependence on the presence of at least three different mouse chromosomes and independence of hamster genome dosage.
Schäfer R; Hoffmann H; Willecke K
Cancer Res; 1983 May; 43(5):2240-6. PubMed ID: 6831446
[TBL] [Abstract][Full Text] [Related]
9. DNA polymorphisms indicate loss of heterozygosity for chromosome 11 of D98AH2 cells.
Kaelbling M; Roginski RS; Klinger HP
Cytogenet Cell Genet; 1986; 41(4):240-4. PubMed ID: 3011364
[TBL] [Abstract][Full Text] [Related]
10. Identification of a human chromosome 11 gene which is differentially regulated in tumorigenic and nontumorigenic somatic cell hybrids of HeLa cells.
Lichy JH; Modi WS; Seuanez HN; Howley PM
Cell Growth Differ; 1992 Aug; 3(8):541-8. PubMed ID: 1390339
[TBL] [Abstract][Full Text] [Related]
11. Stable nontumorigenic phenotype of somatic cell hybrids between malignant Burkitt's lymphoma cells and autologous EBV-immortalized B cells despite induction of chromosomal breakage and loss.
Jox A; Taquia E; Vockerodt M; Draube A; Pawlita M; Möller P; Bullerdiek J; Diehl V; Wolf J
Cancer Res; 1998 Nov; 58(21):4930-9. PubMed ID: 9810002
[TBL] [Abstract][Full Text] [Related]
12. Suggestive evidence for functionally distinct, tumor-suppressor genes on chromosomes 1 and 11 for a human fibrosarcoma cell line, HT1080.
Kugoh HM; Hashiba H; Shimizu M; Oshimura M
Oncogene; 1990 Nov; 5(11):1637-44. PubMed ID: 2267132
[TBL] [Abstract][Full Text] [Related]
13. Suppression of malignancy in human cancer cells: issues and challenges.
Sabin AB
Proc Natl Acad Sci U S A; 1981 Nov; 78(11):7129-33. PubMed ID: 6273913
[TBL] [Abstract][Full Text] [Related]
14. Specific chromosome loss associated with the expression of tumorigenicity in human cell hybrids.
Stanbridge EJ; Flandermeyer RR; Daniels DW; Nelson-Rees WA
Somatic Cell Genet; 1981 Nov; 7(6):699-712. PubMed ID: 7323948
[TBL] [Abstract][Full Text] [Related]
15. Localization of HeLa cell tumor-suppressor gene to the long arm of chromosome II.
Misra BC; Srivatsan ES
Am J Hum Genet; 1989 Oct; 45(4):565-77. PubMed ID: 2577469
[TBL] [Abstract][Full Text] [Related]
16. Loss of a putative tumor suppressor locus after gamma-ray-induced neoplastic transformation of HeLa x skin fibroblast human cell hybrids.
Mendonca MS; Fasching CL; Srivatsan ES; Stanbridge EJ; Redpath JL
Radiat Res; 1995 Jul; 143(1):34-44. PubMed ID: 7597142
[TBL] [Abstract][Full Text] [Related]
17. The suppression of tumorigenicity in human X mouse cell hybrids. I. Derivation of hybrid clones, chromosome analysis and tumorigenicity studies.
Chopan M; Kopelovich L
Exp Cell Biol; 1981; 49(2):78-89. PubMed ID: 7202797
[TBL] [Abstract][Full Text] [Related]
18. Relationship between tumorigenicity and the dosage of lymphoma- vs. normal-parent-derived chromosome 15 in somatic cell hybrids between lymphoma cells with rearranged pvt-1 gene and normal cells.
Uno M; Wirschubsky Z; Wiener F; Klein G
Int J Cancer; 1989 Aug; 44(2):353-9. PubMed ID: 2788146
[TBL] [Abstract][Full Text] [Related]
19. Analysis of oncogene, tumor suppressor gene, and chromosomal alterations in HeLa x osteosarcoma somatic cell hybrids.
Isfort RJ; Cody DB; Lovell GJ; Gioeli D; Weissman BE; Doersen CJ
Mol Carcinog; 1999 May; 25(1):30-41. PubMed ID: 10331742
[TBL] [Abstract][Full Text] [Related]
20. Expression of transformation markers and suppression of tumorigenicity in human cell hybrids.
Larizza L; Tenchini ML; Mottura A; De Carli L; Colombi M; Barlati S
Eur J Cancer Clin Oncol; 1982 Sep; 18(9):845-51. PubMed ID: 6961038
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
